The endocannabinoid system is implicated in a variety of physiological and pathological
conditions (inflammation, immunomodulation, analgesia, cancer and others). The main …

The endocannabinoid system has emerged as an important target for the treatment of many
diverse diseases. In addition to the well‐established palliative effects of cannabinoids in …

Endogenous arachidonic acid metabolites with properties similar to compounds of Cannabis
sativa Linnaeus, the so-called endocannabinoids, have effects on various types of cancer …

In the last two decades, research has dramatically increased the knowledge of cannabinoids
biology and pharmacology. In mammals, compounds with properties similar to active …

In the last few decades, the endocannabinoid system has attracted a great deal of interest in
terms of its applications to clinical medicine. In particular, its applications in cancer probably …

The endocannabinoid system consists of an array of endogenously produced bioactive
lipids that activate cannabinoid receptors. Although the primary focus of endocannabinoid …

Drugs that target the endocannabinoid system are of interest as pharmacological options to
combat cancer and to improve the life quality of cancer patients. From this perspective …

Introduction: Recent studies have shown that the endocannabinoid system (ECS) could offer
an attractive antitumor target. Numerous findings suggest the involvement of this system …

The discovery of the endocannabinoid system and the recognition of its potential impact in a
plethora of pathological conditions, led to the development of therapeutic agents related to …

The endocannabinoid system encompassing cannabinoid receptors, endogenous receptor
ligands (endocannabinoids), as well as enzymes conferring the synthesis and degradation …